Mirko Petrovic

      Mirko Petrovic, MD, PhD is a senior full professor of geriatrics and chairman in the Department of Internal Medicine and Paediatrics at the Faculty of Medicine and Health Sciences, Ghent University), and the lead of the research unit “Quality of drug utilization in older persons”.

      Main Research activities: The main aims of his research line are: to outline the pattern and quality of drug utilisation in older in-patients and patients residing in nursing homes; to assess the quality of prescribing and to estimate to what extent the prescriptions are tailored to real medical needs; to assess to what extent the organisation of an institution influences the relationship between drug utilisation and medical needs; to use prescribing indicators for identification of prescribing which is not in line with national and regional prescribing guidelines and to contribute to the organisation and implementation of a better prescribing policy in older people. His scientific record illustrates extensive experience both in performing epidemiological studies and clinical trials. 

      Bibliometric analysis of CV: Mirko Petrovic is author of 24 book chapters, 318 peer-reviewed publications (of which 213 A1), co-author and co-editor of books, supervisor of 62 dissertations and 10 PhD theses (of which 7 defended). His h-index in the WOS is 61. His work has been presented 133 times at international and 202 times and national congresses and conferences.

      Project Management: Mirko Petrovic did get about €2.000.000 research funding through grants and projects. He participated as a member of the consortium and a co-principal investigator in two European Commission projects: FP7 HEALTH-2011 MID_FRAIL study (A randomized clinical trial to evaluate the effectiveness of a Multi-modal Intervention in older people with type 2 Diabetes on FRAILty and quality of life’) and FP7-HEALTH-2012 SENATOR study (Development and clinical trials of a new Software ENgine for the Assessment & optimization of drug and non-drug Therapy in Older peRsons).  He currently participates in the H2020 AFFIRMO study (Atrial Fibrillation integrated approach in FraIl, multimoRbid and polyMedicated Older people).

      Membership of Scientific Committees and Scholarly boards (not exhaustive): He is the co-chairman of the research alliance group ‘Research in Geriatrics and Gerontology- REGG’ of the Ghent University (UGent) and the Free University of Brussels (VUB). He is also a member of  the Belgian Royal Academy of Medicine, the Belgian Psychotropics Expert Platform (BelPEP) of the federal public service Health, food chain safety and environment, the EMA (European Medicine Agency) Geriatric Expert Group and a member of the following scientific societies: Belgian Society for Gerontology and Geriatrics, Dutch Society for Clinical Pharmacology and Biopharmacy, European Academy for Medicine of Ageing (EAMA) network, European Geriatric Medicine Society (EuGMS) in the capacity of the academic director and International Association for Gerontology and Geriatrics-IAGG. He serves as member of the editorial board and a reviewer of several international peer-reviewed journals.